We are pleased to announce the arrival of Dr. Kevin Felsenstein, Ph.D. as a new member of the CTRND faculty.
Dr. Felsenstein brings over 20 years of research in the pharmaceutical/biotech industry where he specialized in the small molecule drug discovery covering anti-infectives and neuroscience.